By Robert Preidt
The findings may enhance care and save lives through the pandemic, the researchers stated.
“This research is the primary to indicate that the presence of neurological signs, notably stroke and confused or altered pondering, could point out a extra severe course of sickness, even when pulmonary issues aren’t extreme,” stated research co-author Dr. David Altschul, chief of neurovascular surgical procedure at Montefiore Well being System and Albert Einstein Faculty of Drugs in New York Metropolis.
His staff analyzed knowledge on 4,711 COVID-19 sufferers who had been admitted to the Montefiore system between March 1 and April 16. Of these, 581 (12%) had neurological issues severe sufficient for medical doctors to order mind imaging.
These sufferers had been in contrast with a management group of greater than 1,700 COVID-19 sufferers of comparable age and illness severity who did not have neurological signs.
Amongst sufferers who had mind imaging, 55 had been identified with stroke and 258 had confusion or altered pondering potential.
In comparison with the management group, sufferers with stroke had been twice as prone to die (49% versus 24%) and sufferers with confusion additionally had a considerably greater danger of dying (40% versus 33%), based on findings printed on-line Dec. 18 within the journal Neurology.
Greater than half of the stroke sufferers did not have high blood pressure or different underlying danger elements for stroke, researchers famous.
“This extremely uncommon discovering agrees with different research of individuals with COVID-19 in suggesting that an infection with the novel coronavirus is itself a danger issue for stroke,” Altschul stated in a Montefiore information launch.
The Nationwide Library of Drugs has extra on COVID-19.
SOURCE: Montefiore Well being System, information launch, Dec. 18, 2020